FDA Oncology Center Now Aiming For One To Two Labeling Updates Annually Under ‘Project Renewal’

 
• By Sue Sutter
  
First in line
Capecitabine was moved to head of the line for labeling changes under FDA's Project Renewal. • Source: Shutterstock

More from Post-Marketing Regulation & Studies

More from Product Reviews